Αρχειοθήκη ιστολογίου

Παρασκευή 21 Ιουλίου 2017

COX-2 inhibitors may reverse IDO1-mediated immunosuppression in some cancers

(American Association for Cancer Research) In preclinical studies, tumors that consitutively expressed the protein indoleamine 2,3-dioxygenase (IDO1) responded to the cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex) and had improved infiltration of certain subsets of T cells, making them more likely to respond to anti-PD1 therapies. (Source: EurekAlert! - Cancer)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uP7kGD
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader